{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:11:49Z","timestamp":1791270709552,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ijcard.2011.12.080","type":"journal-article","created":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T23:04:26Z","timestamp":1326582266000},"page":"244-249","source":"Crossref","is-referenced-by-count":25,"title":["Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure"],"prefix":"10.1016","volume":"167","author":[{"given":"Shu","family":"Kasama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Kumakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutomo","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kurabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2011.12.080_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","article-title":"Plasma norepinephrine in congestive heart failure","volume":"41","author":"Thomas","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.78.5.1192","article-title":"Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy","volume":"78","author":"Henderson","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0045","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1253\/jcj.65.155","article-title":"Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy","volume":"65","author":"Imamura","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2967\/jnumed.107.047548","article-title":"Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction","volume":"49","author":"Kasama","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2967\/jnumed.107.045427","article-title":"Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure","volume":"48","author":"Kasama","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0075","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1210\/en.2005-1167","article-title":"Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats","volume":"147","author":"Buss","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0080","doi-asserted-by":"crossref","first-page":"46A","DOI":"10.1016\/0002-9149(93)90245-8","article-title":"Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation","volume":"71","author":"Klug","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0085","first-page":"349","article-title":"Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0090","first-page":"1085","article-title":"ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure","volume":"38","author":"Takeishi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0095","first-page":"217","article-title":"Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy","volume":"40","author":"Toyama","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0100","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00259-005-1786-z","article-title":"Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril","volume":"32","author":"Kasama","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2004.11.038","article-title":"Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction","volume":"45","author":"Kasama","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/hrt.2005.062463","article-title":"Comparative effects of valsartan with enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0115","first-page":"1604","article-title":"Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy","volume":"44","author":"Toyama","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/ehm048","article-title":"Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol","volume":"28","author":"Kasama","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0735-1097(02)02855-3","article-title":"Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy","volume":"41","author":"Kasama","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.CIR.97.2.167","article-title":"Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction","volume":"97","author":"Denollet","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","article-title":"Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction","volume":"96","author":"Tsutamoto","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.12.080_bb0150","first-page":"155","article-title":"Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure","volume":"45","author":"Kyuma","year":"2004","journal-title":"J Nucl Med"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311022613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311022613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T02:53:40Z","timestamp":1543287220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527311022613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0167527311022613"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.12.080","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}